The National Pharmaceutical
Pricing Authority has revised/fixed the prices of 13 formulation
packs on 17th February, 2003. The prices have been
fixed for the first time in the case of 8 formulation packs.
In the case of 4 packs the price have been reduced ranging from
1.96% to 51.59%. The revision in prices was warranted due to
downward revision in price of scheduled bulk drug. In the case
of 1 pack price has been increased by 30.25% due to increase
in the price of scheduled bulk drug.
Of the 13 formulation
packs, ceiling prices (exclusive of excise duty and local taxes
etc.) have been fixed in respect of 5 packs. The non-ceiling
prices (inclusive of excise duty but exclusive of local taxes
etc.) have been fixed in respect of 8 packs. The prices have
been fixed/revised in accordance with the provisions of the
Drugs Price Control Order (DPCO), 1995 and as per the established
criteria and guidelines. A copy of the statement showing the
existing (where available) and revised prices is enclosed herewith.
The formulations
for which prices have been revised/fixed are Insulin formulations
used for the treatment of diabeties, Pentazocine based formulations
used as analgesic medicine, Betamethasone based formulations
used in the treatment of skin disorder and Methyldopa formulations
used as Anti-hypertensive medicine.
The prices fixed/revised
would become effective within 15 days from the date of notification
in the official gazette or the receipt of the order of the NPPA
in this behalf, as per Para 14(1) of DPCO, 1995. Necessary revised
price list is to be issued by the manufacturers/importers required
under sub-paragraph (3) of paragraph 14 of the DPCO, 1995. Accordingly,
as per the provision, the revised price list in Form-V of the
DPCO is to be furnished by the concerned manufacturer(s) to
the government and NPPA, State Drug Control Authorities and
distributors, wholesalers and retailers or any other agent.
The manufacturers
are also required to work out the pro-rata prices of different
pack sizes as the case may be in terms of S.O. No. 83 (E) dated
27.01.98.
Click here for the Statement
